Brief Report: Heterogeneity of Acquired Resistance Mechanisms to Osimertinib and Savolitinib
{{output}}
Introduction: MET amplification is a frequently observed mechanism of resistance to osimertinib, and coinhibition strategy of MET and EGFR revealed promising results in recent clinical trials. Nevertheless, acquired resistance me... ...
